<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12-pharmaceutics-09-00048" class="ref">
 <label class="label">12.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Müller</surname>
    <given-names class="given-names">R.H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Mäder</surname>
    <given-names class="given-names">K.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Gohla</surname>
    <given-names class="given-names">S.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Solid lipid nanoparticles (SLN) for controlled drug delivery—A review of the state of the art</article-title>
  <source class="source">Eur. J. Pharm. Biopharm.</source>
  <year class="year">2000</year>
  <volume class="volume">50</volume>
  <fpage class="fpage">161</fpage>
  <lpage class="lpage">177</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/S0939-6411(00)00087-4</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">10840199</pub-id>
 </element-citation>
</ref>
